Comparative study on the effects of calcium antagonists on central blood pressure

Comparative study on the effects of calcium antagonists on central blood pressure - Azeldinipine study

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000003323

Enrollment

Registered

2010-04-01

Start date

2009-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic kidney disease

Interventions

azeldinipine amlodipine

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Among the patients with CKD, the subjucts of this test would be those with high blood pressure despite of antihypertensive treatent. Envelop method was used to devide into 2 groups. One group should take amlodipine, and the other group do azeldinipine.

Exclusion criteria

Exclusion criteria: Exclusion criteria would be uncontrolable hypertension, sustained hypotension, rapid increase in serum creatinine, the start of renal replacement therapy.

Design outcomes

Primary

Measure	Time frame
AI,urinary protein,eGFR	—

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026